Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
41.47
-1.49 (-3.47%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $253.49 million as of April 24, 2025. Its market cap has increased by 2,312.38% in one year.
Market Cap
253.49M
Enterprise Value
193.28M
1-Year Change
2,312.38%
Ranking
Category
Stock Price
$41.47
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has decreased from $276.16M to $253.49M, a decrease of -8.21%. That is a compound annual growth rate of -1.59%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.94B |
| UnitedHealth Group | 388.10B |
| Johnson & Johnson | 372.48B |
| AbbVie | 311.76B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 224.33B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |